Date: 12 Dec 2012
Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis
The aim of this meta-analysis is to determine the predictive value of diabetic retinopathy in differentiating diabetic nephropathy from non-diabetic renal diseases in patients with type 2 diabetes and renal disease.
Medline and Embase databases were searched from inception to February 2012. Renal biopsy studies of participants with type 2 diabetes were included if they contained data with measurements of diabetic retinopathy. Pooled sensitivity, specificity, positive predictive value, negative predictive value and other diagnostic indices were evaluated using a random-effects model.
The meta-analysis investigated 26 papers with 2012 patients. The pooled sensitivity and specificity of diabetic retinopathy to predict diabetic nephropathy were 0.65 (95% CI 0.62, 0.68) and 0.75 (95% CI 0.73, 0.78), respectively. The pooled positive and negative predictive value of diabetic retinopathy to predict diabetic nephropathy were 0.72 (95% CI 0.68, 0.75) and 0.69 (95% CI 0.67, 0.72), respectively. The area under the summary receiver operating characteristic curve was 0.75, and the diagnostic odds ratio was 5.67 (95% CI 3.45, 9.34). For proliferative diabetic retinopathy, the pooled sensitivity was 0.25 (95% CI 0.16, 0.35), while the specificity was 0.98 (95% CI 0.92, 1.00). There was heterogeneity among studies (p < 0.001), and no publishing bias was identified.
Diabetic retinopathy is useful in diagnosing or screening for diabetic nephropathy in patients with type 2 diabetes and renal disease. Proliferative diabetic retinopathy may be a highly specific indicator for diabetic nephropathy.
F. He and X. Xia contributed equally to this study.
The International Diabetes Federation (2011) International Diabetes Federation’s 5th edition of the Diabetes atlas, 5th edn. Available from www.idf.org, accessed 10 March 2012
Centers for Disease Control and Prevention (2011) National diabetes fact sheet. Available from www.cdc.gov, accessed 10 March 2012
KDOQI (2007) KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49:S12–S154CrossRef
Renal Data System US (2011) USRDS 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. US Renal Data System, Bethesda
Lee EY, Chung CH, Choi SO (1999) Non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus. Yonsei Med J 40:321–326PubMed
Prakash J, Sen D, Usha et al (2001) Non-diabetic renal disease in patients with type 2 diabetes mellitus. J Assoc Phys India 49:415–420
Zukowska-Szczechowska E, Tomaszewski M (2004) Renal affection in patients with diabetes mellitus is not always caused by diabetic nephropathy. Rocz Akad Med Bialymst 49:185–189PubMed
Der Simonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRef
Zamora J, Abraira V, Muriel A, Khan KS, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Meth 6:31CrossRef
Brocco E, Fioretto P, Mauer M et al (1997) Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria. Kidney Int Suppl 63:S40–S44PubMed
Christensen PK, Gall MA, Parving HH (2000) Course of glomerular filtration rate in albuminuric type 2 diabetic patients with or without diabetic glomerulopathy. Diabetes Care 23:B14–B20PubMed
Kleinknecht D, Bennis D, Altman JJ (1992) Increased prevalence of non-diabetic renal pathology in type II diabetes mellitus. Nephrol Dial Transplant 7:1258–1259PubMed
Richards NT, Greaves I, Lee SJ, Howie AJ, Adu D, Michael J (1992) Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus. Nephrol Dial Transplant 7:397–399PubMed
Huang F, Yang Q, Chen L, Tang S, Liu W, Yu X (2007) Renal pathological change in patients with type 2 diabetes is not always diabetic nephropathy: a report of 52 cases. Clin Nephrol 67:293–297PubMed
Chawarnkul O, Vareesangthip K, Ongajyooth L, Cheunsuchon B, Parichatikanond P (2009) Non-diabetic glomerular disease in type II DM: 10 years experience. J Med Assoc Thai 92:S57–S60PubMed
National Health and Medical Research Council (2008) Guidelines for the management of diabetic retinopathy. Commonwealth of Australia, Canberra
UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 12(352):854–865
UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:708–713
ACCORD Study Group, ACCORD Eye Study Group, Chew EY et al (2008) Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 363:233–244CrossRef
- Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis
Volume 56, Issue 3 , pp 457-466
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Diabetic nephropathy
- Diabetic retinopathy
- Non-diabetic renal disease
- Renal biopsy
- Type 2 diabetes
- Industry Sectors